IC
YARW

Ikarian Capital’s Yarrow Bioscience YARW Stock Holding History

Ikarian Capital’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Hold
5,298
– – 0.02% 142
2026
Q1 		$158K Hold
5,298
– – 0.01% 143
2025
Q4 		$154K Sell
5,298
-502
-9% -$10.1K 0.01% 157
2025
Q3 		$97.1K Hold
5,800
– – 0.01% 163
2025
Q2 		$479K Buy
+5,800
New +$377K 0.09% 92

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ikarian Capital's YARW Position: Q2 2026 in Review

Ikarian Capital held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 5,298 shares worth $172K. The position accounts for 0.02% of the portfolio, ranked #142.

Ikarian Capital first reported a position in YARW in Q2 2025 and has held it in 5 quarters since. The position peaked at $479K in Q2 2025. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Ikarian Capital held 5,298 shares of Yarrow Bioscience worth $172K as of Q2 2026.
  • Ikarian Capital left its Yarrow Bioscience share count unchanged in Q2 2026.
  • Yarrow Bioscience made up 0.02% of Ikarian Capital's portfolio in Q2 2026, its #142 holding.
  • Ikarian Capital first reported a position in Yarrow Bioscience in Q2 2025 and has held it in 5 quarters since.
  • Ikarian Capital's Yarrow Bioscience position peaked at $479K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.